Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
95.08
+3.02 (+3.29%)
Delayed Quote
Updated: 9:51 AM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
What Analysts Are Saying About BioNTech Stock
↗
September 08, 2025
Via
Benzinga
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
September 08, 2025
From
Pfizer Inc.
Via
Business Wire
Why BioNTech Stock Crushed the Market Today
↗
September 05, 2025
The company might be close to commercializing its most advanced pipeline program.
Via
The Motley Fool
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday
↗
September 05, 2025
Via
Benzinga
Why Did BioNTech Stock Surge 10% Pre-Market Today?
↗
September 05, 2025
Via
Stocktwits
Pfizer, BioNTech Get FDA Clearance For Updated Covid Vaccine In Senior Adults And Younger At-Risk Population
↗
August 27, 2025
Via
Stocktwits
Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?
↗
September 05, 2025
It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.
Via
Investor's Business Daily
BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb
↗
September 05, 2025
The company's DualityBio-partnered drug met the pre-specified bar for success in a pivotal study.
Via
Investor's Business Daily
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data
↗
September 05, 2025
BioNTech and DualityBio reported Phase 3 success for trastuzumab pamirtecan in HER2 breast cancer, setting stage for regulatory submission in China.
Via
Benzinga
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works
↗
September 01, 2025
Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
Via
Benzinga
Breaking Down BioNTech: 12 Analysts Share Their Views
↗
August 05, 2025
Via
Benzinga
BioNTech Gets Price Target Bumps From BofA, Clear Street After Strong Q2, Oncology Pipeline Push
↗
August 04, 2025
Via
Stocktwits
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
A Look Ahead: BioNTech's Earnings Forecast
↗
August 01, 2025
Via
Benzinga
Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio?
↗
August 31, 2025
Marvell, Hormel, and Keurig Dr Pepper led weekly large-cap losers on weak guidance and analyst downgrades.
Via
Benzinga
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
↗
August 27, 2025
FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing.
Via
Benzinga
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.
↗
August 27, 2025
Shares of one vaccine-maker are under pressure on Robert F. Kennedy Jr.'s move on Wednesday.
Via
Investor's Business Daily
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 27, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 27, 2025
From
BioNTech SE
Via
GlobeNewswire
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'
↗
August 25, 2025
The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.
Via
Benzinga
Topics
Government
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
↗
August 13, 2025
This big pharma company's juicy dividend is looking even more attractive.
Via
The Motley Fool
Topics
Earnings
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
↗
August 12, 2025
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.
Via
Benzinga
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
↗
August 11, 2025
Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.
Via
Benzinga
These Analysts Revise Their Forecasts On BioNTech After Q2 Results
↗
August 05, 2025
Via
Benzinga
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
↗
August 04, 2025
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.
Via
Benzinga
BioNTech SE (NASDAQ:BNTX) Q2 2025 Earnings: Revenue Surges 68.5%, Losses Narrower Than Expected
↗
August 04, 2025
BioNTech Q2 2025 earnings beat revenue estimates with $255.99M, narrowing losses to -$1.57 EPS. Shares rose 2% pre-market as oncology pipeline advances.
Via
Chartmill
Topics
Earnings
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
August 04, 2025
From
BioNTech SE
Via
GlobeNewswire
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
August 04, 2025
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Moderna's Key Patent Win Overshadowed By Gloomy Outlook
↗
August 01, 2025
Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce.
Via
Benzinga
Topics
Intellectual Property
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
↗
July 31, 2025
Bristol Myers beat Q2 sales expectations but cut its 2025 EPS forecast as strategic charges and legacy product declines weighed on earnings.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
73
74
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
